Csenge Advisory Group Q3 2022 Filing

Filed October 4, 2022

Portfolio Value

$1.2T

Holdings

609

Report Date

Q3 2022

Filing Type

13F-HR

All Holdings (609 positions)

#StockSharesValue% PortfolioType
601
CVM1EURCEL-SCI CORP
10,700$33.0M0.00%
602
KULRKULR TECHNOLOGY GROUP INC
25,477$33.0M0.00%
603
CGENCOMPUGEN LTD
41,345$27.0M0.00%
604
EVGNEVOGENE LTD
31,962$27.0M0.00%
605
AMRNAMARIN CORP PLC
22,264$24.0M0.00%
606
CTXRCITIUS PHARMACEUTICALS INC
15,000$18.0M0.00%
607
AGPUPREDICTIVE ONCOLOGY INC
39,500$14.0M0.00%
608
PRQRPROQR THRAPEUTICS N V
10,000$7.0M0.00%
609
KALAKALA PHARMACEUTICALS INC
19,924$4.0M0.00%
PreviousPage 7 of 7